Zotiraciclib is a pharmaceutical compound under investigation in clinical trials for recurrent anaplastic astrocytoma and glioblastoma. It is supplied as an active pharmaceutical ingredient for research and manufacturing purposes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Zotiraciclib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Anastrozole
pharmaceutical raw material
Dolutegravir o-benzyl impurity
pharmaceutical raw material
Etrasimod
pharmaceutical raw material
Etrasimod arginine
pharmaceutical raw material
The international HS code for Zotiraciclib (CAS 1204918-72-8) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(16E)-14-methyl-20-oxa-5,7,14,27-tetrazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2(27),3,5,8,10,12(26),16,21,23-decaene
VXBAJLGYBMTJCY-NSCUHMNNSA-N
CN1C/C=C/CCOC2=CC=CC(=C2)C3=NC(=NC=C3)NC4=CC=CC(=C4)C1
Sourcing Zotiraciclib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.